Inhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease
- 16 November 2002
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 54 (11), 1463-1474
- https://doi.org/10.1016/s0169-409x(02)00154-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Inhibition of Amiloride-Sensitive Epithelial Na+ Absorption by Extracellular Nucleotides in Human Normal and Cystic Fibrosis AirwaysAmerican Journal of Respiratory Cell and Molecular Biology, 2000
- Intermittent Administration of Inhaled Tobramycin in Patients with Cystic FibrosisNew England Journal of Medicine, 1999
- Evidence for Periciliary Liquid Layer Depletion, Not Abnormal Ion Composition, in the Pathogenesis of Cystic Fibrosis Airways DiseaseCell, 1998
- Coordinated clearance of periciliary liquid and mucus from airway surfaces.Journal of Clinical Investigation, 1998
- Cystic fibrosis.American Journal of Respiratory and Critical Care Medicine, 1996
- Management of Pulmonary Disease in Patients with Cystic FibrosisNew England Journal of Medicine, 1996
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisNew England Journal of Medicine, 1994
- Effect of extracellular ATP and UTP on fluid transport by human nasal epithelial cells in culture.American Journal of Respiratory Cell and Molecular Biology, 1994
- Activation by Extracellular Nucleotides of Chloride Secretion in the Airway Epithelia of Patients with Cystic FibrosisNew England Journal of Medicine, 1991
- Regulation of transepithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epitheliumBritish Journal of Pharmacology, 1991